|
|
| | Pyridine, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-methyl- Basic information |
| Product Name: | Pyridine, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-methyl- | | Synonyms: | Pyridine, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-methyl-;5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-methyl-Pyridine;2-(difluoromethyl)-5-(6-methyl-3-pyridyl)-1,3,4-oxadiazole | | CAS: | 2071232-29-4 | | MF: | C9H7F2N3O | | MW: | 211.17 | | EINECS: | | | Product Categories: | | | Mol File: | 2071232-29-4.mol | ![Pyridine, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-methyl- Structure](CAS/20200611/GIF/2071232-29-4.gif) |
| | Pyridine, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-methyl- Chemical Properties |
| Boiling point | 299.3±50.0 °C(Predicted) | | density | 1.308±0.06 g/cm3(Predicted) | | pka | 2.45±0.12(Predicted) |
| | Pyridine, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-methyl- Usage And Synthesis |
| Uses | 2-(Difluoromethyl)-5-(6-methylpyridin-3-yl)-1,3,4-oxadiazole is used as a reactant in the preparation of oxadiazole sulfonamide derivatives as HDAC6 inhibitors. |
| | Pyridine, 5-[5-(difluoromethyl)-1,3,4-oxadiazol-2-yl]-2-methyl- Preparation Products And Raw materials |
|